| Price | 0.60p on 10-11-2026 at 09:45:11 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.65p |
| Sell | 0.55p |
| Last Trade: | Buy 300,000.00 at 0.601p |
| Day's Volume: | 783,235 |
| Last Close: | 0.60p |
| Open: | 0.60p |
| ISIN: | GB0034330679 |
| Day's Range | 0.60p - 0.60p |
| 52wk Range: | 0.575p - 2.50p |
| Market Capitalisation: | £6.82m |
| VWAP: | 0.613768p |
| Shares in Issue: | 1.14b |
Cellbxhealth (CLBX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 300,000 | 0.601p | Ordinary |
08:58:05 - 10-Nov-26 |
| Buy* | 361,500 | 0.629p | Ordinary |
08:50:00 - 10-Nov-26 |
| Sell* | 121,735 | 0.60p | Ordinary |
08:03:43 - 10-Nov-26 |
| Buy* | 78,436 | 0.629p | Ordinary |
15:33:49 - 09-Nov-26 |
| Sell* | 24,631 | 0.60p | Ordinary |
14:53:24 - 09-Nov-26 |
| Sell* | 3,846 | 0.60p | Ordinary |
14:40:44 - 09-Nov-26 |
| Buy* | 158,222 | 0.6295p | Ordinary |
11:38:08 - 09-Nov-26 |
| Sell* | 6,482 | 0.587p | Ordinary |
11:37:00 - 09-Nov-26 |
| Buy* | 400,000 | 0.635p | Ordinary |
10:34:46 - 09-Nov-26 |
| Buy* | 40,000 | 0.6295p | Ordinary |
10:08:45 - 09-Nov-26 |
Cellbxhealth (CLBX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Oct 2026 7:00 am | RNS | Q3 Trading Update and FY 2026 Outlook |
| 21st Oct 2026 7:00 am | RNS | Master Services Agreement with Swiss biotech co |
| 14th Oct 2026 7:00 am | RNS | New Statement of Work with US-Based Pharma Company |
| 11th Aug 2026 7:00 am | RNS | Parsortix CTCs used for Brain Cancer detection |
| 3rd Aug 2026 7:00 am | RNS | Parsortix CTCs used for ADC target assessment |
| 16th Jul 2026 7:00 am | RNS | Issue of Share Options |
| 15th Jul 2026 7:00 am | RNS | Q2 and First Half Year Results ended 30 June 2026 |
| 14th Jul 2026 9:46 am | RNS | Result of AGM |
| 14th Jul 2026 7:00 am | RNS | AGM Statement |
| 6th Jul 2026 4:45 pm | RNS | Directorate change |
